GlassScriptPhysician profile
Elizabeth Lopez
NPI 1255494431
$1,725.38
in general payments reported to CMS, 2019-2025
21 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $623 · 2022: $466 · 2023: $161 · 2024: $276 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $392.07 | 2021-2025 | Eterna, Freestyle Libre 3, Proclaim |
| Novartis Pharmaceuticals Corporation | $359.73 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.10 | 2022-2025 | |
| Redhill Biopharma INC. | $116.15 | 2021 | |
| Abbvie INC. | $107.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $98.45 | 2021 | |
| Sanofi Pasteur INC. | $84.67 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.60 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $56.96 | 2022-2023 | Ozempic |
| Boston Scientific Corporation | $39.61 | 2021-2022 | |
| Lucid Diagnostics INC. | $35.49 | 2022 | |
| Recordati_rare_diseases_inc. | $34.82 | 2024-2025 | Isturisa, Signifor Lar |
| Actelion Pharmaceuticals US, INC. | $25.22 | 2023 | Opsumit, Uptravi |
| Phadia US INC. | $23.06 | 2023 | Immunocap |
| Exact Sciences Corporation | $18.27 | 2023 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.63 | 2025 | Zepbound, Mounjaro |
| Corcept Therapeutics | $16.65 | 2025 | Korlym |
| Cequr Corporation | $16.51 | 2024 | Cequr Simplicity |
| Pfizer INC. | $16.13 | 2022 | |
| Merck Sharp & Dohme LLC | $13.83 | 2023 | Vaxneuvance, Rotateq, Gardasil 9 |
| Arbor Pharmaceuticals, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.